Blue Cross Insurers To Create Their Own Drug Company Amid Price Fight

  • 📰 Forbes
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 53%

United States News News

United States United States Latest News,United States United States Headlines

Blue Cross and Blue Shield health insurers are launching their own nonprofit drug company with Civica Rx to create alternatives to “high-cost” generics that haven’t come down in price.

and seven hospital systems, Civica now represents more than 1,200 U.S. hospitals that say they are already benefitting from lower cost injectable drugs including antibiotics once in short supply.

Many of these same Blue Cross and Blue Shield plans already own their own pharmacy benefit management company inor use the Express Scripts PBM owned by Cigna or CVS Health’s Caremark PBM. These PBMs work as middlemen of sorts to buy drugs in bulk from manufacturers and wholesalers and leverage their clout to get better deals on prescriptions for consumers, patients and health plan customers.

The Blue Cross plans have yet to disclose which generic drugs they plan to develop first but one likely target could be insulin, which continues to have a price tag frustrating health plans even though it remains available as a generic.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

As long as the quality is there in the generic... I feel sorry tho for people on multiple pills who only track them by color & shape. Hopefully electronic records can be accessed by hospitals whose health professionals have no way of recognizing all the different generics.

The vessel keeps shifting course...Will we ever sail calm waters?

My cousins 😂😂😭🙏😍🙏😍

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in US

United States United States Latest News, United States United States Headlines